A study conducted by Eggers et al. (Eggers et al., 2011) indicated the release of S100A9 could lead to increased cardiovascular risk and another study (Volz et al., 2012) showed that S100A9 knockdown could cause reduced cellular proliferation, neointimal formation and atherosclerosis. The gene discussed is S100A9; the disease is atherosclerosis.